Funded Tech Companies

Blueprint Medicines

Headquartered in Cambridge, Blueprint Medicines raised its funding from Tavistock Life Sciences, Partner Fund Management and Sabby Capital.

Company Overview

Contact Information

Company Background Information

Overview

Blueprint Medicines discovers and develops highly selective kinase inhibitors for patients with genomically defined cancers.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

4/30/2015

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Jeffery Albers

        

Chief Medical Officer

Anthony Boral

        

Chief Scientific Officer

Marion Dorsch

        

Executive Vice President

Christoph Lengauer

        

VP - Bus. Development

Kate Haviland

        

VP - Finance

Michael Landsittel

        

VP - General Counsel

Tracey McCain

        

VP - Human Resources

Debbie Durso-Bumpus

        

VP - Operations

Christopher Murray

        

Company Investors

• Tavistock Life Sciences
• Partner Fund Management (Alex Virgilio)
• Sabby Capital
• Cowen Capital Partners
• Third Rock Ventures (Alexis Borisy)
• Wellington Management Company
• Nextech Invest (Thilo Schroeder)
• F-Prime Capital
• RA Capital
• Casdin Capital
• Perceptive Advisors
• Redmile Group
• F-Prime Capital (Stephen Knight)
• Third Rock Ventures (Alexis Borisey)

Browse more funded tech companies:

Blueprint Labs | Blueprint Power

Share this article

About Our VC Funding Database

Our data comes from VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary